Global Radiopharmaceuticals Market Research Report 2020

Global Radiopharmaceuticals Market Research Report 2020

Table of Contents
1 Radiopharmaceuticals Market Overview
1.1 Product Overview and Scope of Radiopharmaceuticals
1.2 Radiopharmaceuticals Segment by Type
1.2.1 Global Radiopharmaceuticals Sales Growth Rate Comparison by Type (2021-2026)
1.2.2 Diagnostic Radioisotopes
1.2.3 Therapeutic Radioisotopes
1.3 Radiopharmaceuticals Segment by Application
1.3.1 Radiopharmaceuticals Sales Comparison by Application: 2020 VS 2026
1.3.2 Oncology
1.3.3 Cardiology
1.3.4 Other
1.4 Global Radiopharmaceuticals Market Size Estimates and Forecasts
1.4.1 Global Radiopharmaceuticals Revenue 2015-2026
1.4.2 Global Radiopharmaceuticals Sales 2015-2026
1.4.3 Radiopharmaceuticals Market Size by Region: 2020 Versus 2026
2 Global Radiopharmaceuticals Market Competition by Manufacturers
2.1 Global Radiopharmaceuticals Sales Market Share by Manufacturers (2015-2020)
2.2 Global Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
2.3 Global Radiopharmaceuticals Average Price by Manufacturers (2015-2020)
2.4 Manufacturers Radiopharmaceuticals Manufacturing Sites, Area Served, Product Type
2.5 Radiopharmaceuticals Market Competitive Situation and Trends
2.5.1 Radiopharmaceuticals Market Concentration Rate
2.5.2 Global Top 5 and Top 10 Players Market Share by Revenue
2.5.3 Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
2.7 Primary Interviews with Key Radiopharmaceuticals Players (Opinion Leaders)
3 Radiopharmaceuticals Retrospective Market Scenario by Region
3.1 Global Radiopharmaceuticals Retrospective Market Scenario in Sales by Region: 2015-2020
3.2 Global Radiopharmaceuticals Retrospective Market Scenario in Revenue by Region: 2015-2020
3.3 North America Radiopharmaceuticals Market Facts & Figures by Country
3.3.1 North America Radiopharmaceuticals Sales by Country
3.3.2 North America Radiopharmaceuticals Sales by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Radiopharmaceuticals Market Facts & Figures by Country
3.4.1 Europe Radiopharmaceuticals Sales by Country
3.4.2 Europe Radiopharmaceuticals Sales by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Radiopharmaceuticals Market Facts & Figures by Region
3.5.1 Asia Pacific Radiopharmaceuticals Sales by Region
3.5.2 Asia Pacific Radiopharmaceuticals Sales by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Radiopharmaceuticals Market Facts & Figures by Country
3.6.1 Latin America Radiopharmaceuticals Sales by Country
3.6.2 Latin America Radiopharmaceuticals Sales by Country
3.6.3 Mexico
3.6.3 Brazil
3.6.3 Argentina
3.7 Middle East and Africa Radiopharmaceuticals Market Facts & Figures by Country
3.7.1 Middle East and Africa Radiopharmaceuticals Sales by Country
3.7.2 Middle East and Africa Radiopharmaceuticals Sales by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 U.A.E
4 Global Radiopharmaceuticals Historic Market Analysis by Type
4.1 Global Radiopharmaceuticals Sales Market Share by Type (2015-2020)
4.2 Global Radiopharmaceuticals Revenue Market Share by Type (2015-2020)
4.3 Global Radiopharmaceuticals Price Market Share by Type (2015-2020)
4.4 Global Radiopharmaceuticals Market Share by Price Tier (2015-2020): Low-End, Mid-Range and High-End
5 Global Radiopharmaceuticals Historic Market Analysis by Application
5.1 Global Radiopharmaceuticals Sales Market Share by Application (2015-2020)
5.2 Global Radiopharmaceuticals Revenue Market Share by Application (2015-2020)
5.3 Global Radiopharmaceuticals Price by Application (2015-2020)
6 Company Profiles and Key Figures in Radiopharmaceuticals Business
6.1 Bracco Imaging
6.1.1 Corporation Information
6.1.2 Bracco Imaging Description, Business Overview and Total Revenue
6.1.3 Bracco Imaging Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.1.4 Bracco Imaging Products Offered
6.1.5 Bracco Imaging Recent Development
6.2 Bayer
6.2.1 Bayer Radiopharmaceuticals Production Sites and Area Served
6.2.2 Bayer Description, Business Overview and Total Revenue
6.2.3 Bayer Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.2.4 Bayer Products Offered
6.2.5 Bayer Recent Development
6.3 Mallinckrodt
6.3.1 Mallinckrodt Radiopharmaceuticals Production Sites and Area Served
6.3.2 Mallinckrodt Description, Business Overview and Total Revenue
6.3.3 Mallinckrodt Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.3.4 Mallinckrodt Products Offered
6.3.5 Mallinckrodt Recent Development
6.4 Nordion
6.4.1 Nordion Radiopharmaceuticals Production Sites and Area Served
6.4.2 Nordion Description, Business Overview and Total Revenue
6.4.3 Nordion Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 Nordion Products Offered
6.4.5 Nordion Recent Development
6.5 Triad Isotopes
6.5.1 Triad Isotopes Radiopharmaceuticals Production Sites and Area Served
6.5.2 Triad Isotopes Description, Business Overview and Total Revenue
6.5.3 Triad Isotopes Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.5.4 Triad Isotopes Products Offered
6.5.5 Triad Isotopes Recent Development
6.6 Lantheus
6.6.1 Lantheus Radiopharmaceuticals Production Sites and Area Served
6.6.2 Lantheus Description, Business Overview and Total Revenue
6.6.3 Lantheus Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.6.4 Lantheus Products Offered
6.6.5 Lantheus Recent Development
6.7 IBA Group
6.6.1 IBA Group Radiopharmaceuticals Production Sites and Area Served
6.6.2 IBA Group Description, Business Overview and Total Revenue
6.6.3 IBA Group Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.4.4 IBA Group Products Offered
6.7.5 IBA Group Recent Development
6.8 GE Healthcare
6.8.1 GE Healthcare Radiopharmaceuticals Production Sites and Area Served
6.8.2 GE Healthcare Description, Business Overview and Total Revenue
6.8.3 GE Healthcare Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.8.4 GE Healthcare Products Offered
6.8.5 GE Healthcare Recent Development
6.9 China Isotope & Radiation
6.9.1 China Isotope & Radiation Radiopharmaceuticals Production Sites and Area Served
6.9.2 China Isotope & Radiation Description, Business Overview and Total Revenue
6.9.3 China Isotope & Radiation Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.9.4 China Isotope & Radiation Products Offered
6.9.5 China Isotope & Radiation Recent Development
6.10 Jubilant Pharma
6.10.1 Jubilant Pharma Radiopharmaceuticals Production Sites and Area Served
6.10.2 Jubilant Pharma Description, Business Overview and Total Revenue
6.10.3 Jubilant Pharma Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.10.4 Jubilant Pharma Products Offered
6.10.5 Jubilant Pharma Recent Development
6.11 Eli Lilly
6.11.1 Eli Lilly Radiopharmaceuticals Production Sites and Area Served
6.11.2 Eli Lilly Radiopharmaceuticals Description, Business Overview and Total Revenue
6.11.3 Eli Lilly Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.11.4 Eli Lilly Products Offered
6.11.5 Eli Lilly Recent Development
6.12 Advanced Accelerator Applications
6.12.1 Advanced Accelerator Applications Radiopharmaceuticals Production Sites and Area Served
6.12.2 Advanced Accelerator Applications Radiopharmaceuticals Description, Business Overview and Total Revenue
6.12.3 Advanced Accelerator Applications Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.12.4 Advanced Accelerator Applications Products Offered
6.12.5 Advanced Accelerator Applications Recent Development
6.13 SIEMENS
6.13.1 SIEMENS Radiopharmaceuticals Production Sites and Area Served
6.13.2 SIEMENS Radiopharmaceuticals Description, Business Overview and Total Revenue
6.13.3 SIEMENS Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.13.4 SIEMENS Products Offered
6.13.5 SIEMENS Recent Development
6.14 Dongcheng
6.14.1 Dongcheng Radiopharmaceuticals Production Sites and Area Served
6.14.2 Dongcheng Radiopharmaceuticals Description, Business Overview and Total Revenue
6.14.3 Dongcheng Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.14.4 Dongcheng Products Offered
6.14.5 Dongcheng Recent Development
6.15 Navidea
6.15.1 Navidea Radiopharmaceuticals Production Sites and Area Served
6.15.2 Navidea Radiopharmaceuticals Description, Business Overview and Total Revenue
6.15.3 Navidea Radiopharmaceuticals Sales, Revenue and Gross Margin (2015-2020)
6.15.4 Navidea Products Offered
6.15.5 Navidea Recent Development
7 Radiopharmaceuticals Manufacturing Cost Analysis
7.1 Radiopharmaceuticals Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Raw Materials Price Trend
7.1.3 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Radiopharmaceuticals
7.4 Radiopharmaceuticals Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Radiopharmaceuticals Distributors List
8.3 Radiopharmaceuticals Customers
9 Market Dynamics
9.1 Market Trends
9.2 Opportunities and Drivers
9.3 Challenges
9.4 Porter's Five Forces Analysis
10 Global Market Forecast
10.1 Global Radiopharmaceuticals Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Radiopharmaceuticals by Type (2021-2026)
10.1.2 Global Forecasted Revenue of Radiopharmaceuticals by Type (2021-2026)
10.2 Radiopharmaceuticals Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Radiopharmaceuticals by Application (2021-2026)
10.2.2 Global Forecasted Revenue of Radiopharmaceuticals by Application (2021-2026)
10.3 Radiopharmaceuticals Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Radiopharmaceuticals by Region (2021-2026)
10.3.2 Global Forecasted Revenue of Radiopharmaceuticals by Region (2021-2026)
10.4 North America Radiopharmaceuticals Estimates and Projections (2021-2026)
10.5 Europe Radiopharmaceuticals Estimates and Projections (2021-2026)
10.6 Asia Pacific Radiopharmaceuticals Estimates and Projections (2021-2026)
10.7 Latin America Radiopharmaceuticals Estimates and Projections (2021-2026)
10.8 Middle East and Africa Radiopharmaceuticals Estimates and Projections (2021-2026)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
Table 1. Global Radiopharmaceuticals Sales (K Dose) Growth Rate Comparison by Type (2015-2026)
Table 2. Global Radiopharmaceuticals Sales (K Dose) Comparison by Application: 2020 VS 2026
Table 3. Global Radiopharmaceuticals Market Size by Type (K Dose) (US$ Million) (2020 VS 2026)
Table 4. Global Key Radiopharmaceuticals Manufacturers Covered in This Study
Table 5. Global Radiopharmaceuticals Sales (K Dose) by Manufacturers (2015-2020)
Table 6. Global Radiopharmaceuticals Sales Share by Manufacturers (2015-2020)
Table 7. Global Radiopharmaceuticals Revenue (Million USD) by Manufacturers (2015-2020)
Table 8. Global Radiopharmaceuticals Revenue Share by Manufacturers (2015-2020)
Table 9. Global Market Radiopharmaceuticals Average Price (USD/Dose) of Key Manufacturers (2015-2020)
Table 10. Manufacturers Radiopharmaceuticals Sales Sites and Area Served
Table 11. Manufacturers Radiopharmaceuticals Product Types
Table 12. Global Radiopharmaceuticals Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Radiopharmaceuticals by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Radiopharmaceuticals as of 2019)
Table 14.Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Main Points Interviewed from Key Radiopharmaceuticals Players
Table 16. Global Radiopharmaceuticals Sales (K Dose) by Region (2015-2020)
Table 17. Global Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 18. Global Radiopharmaceuticals Revenue (Million US$) by Region (2015-2020)
Table 19. Global Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 20. North America Radiopharmaceuticals Sales by Country (2015-2020) (K Dose)
Table 21. North America Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 22. North America Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 23. North America Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 24. Europe Radiopharmaceuticals Sales by Country (2015-2020) (K Dose)
Table 25. Europe Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 26. Europe Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 27. Europe Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 28. Asia Pacific Radiopharmaceuticals Sales by Region (2015-2020) (K Dose)
Table 29. Asia Pacific Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Table 30. Asia Pacific Radiopharmaceuticals Revenue by Region (2015-2020) (US$ Million)
Table 31. Asia Pacific Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Table 32. Latin America Radiopharmaceuticals Sales by Country (2015-2020) (K Dose)
Table 33. Latin America Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 34. Latin America Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 35. Latin America Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 36. Middle East and Africa Radiopharmaceuticals Sales by Country (2015-2020) (K Dose)
Table 37. Middle East and Africa Radiopharmaceuticals Sales Market Share by Country (2015-2020)
Table 38. Middle East and Africa Radiopharmaceuticals Revenue by Country (2015-2020) (US$ Million)
Table 39. Middle East and Africa Radiopharmaceuticals Revenue Market Share by Country (2015-2020)
Table 40. Global Radiopharmaceuticals Sales (K Dose) by Type (2015-2020)
Table 41. Global Radiopharmaceuticals Sales Share by Type (2015-2020)
Table 42. Global Radiopharmaceuticals Revenue (Million US$) by Type (2015-2020)
Table 43. Global Radiopharmaceuticals Revenue Share by Type (2015-2020)
Table 44. Global Radiopharmaceuticals Price (USD/Dose) by Type (2015-2020)
Table 45. Global Radiopharmaceuticals Sales (K Dose) by Application (2015-2020)
Table 46. Global Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Table 47. Global Radiopharmaceuticals Sales Growth Rate by Application (2015-2020)
Table 48. Bracco Imaging Radiopharmaceuticals Corporation Information
Table 49. Bracco Imaging Description and Business Overview
Table 50. Bracco Imaging Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 51. Bracco Imaging Main Product
Table 52. Bracco Imaging Recent Development
Table 53. Bayer Radiopharmaceuticals Corporation Information
Table 54. Bayer Corporation Information
Table 55. Bayer Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 56. Bayer Main Product
Table 57. Bayer Recent Development
Table 58. Mallinckrodt Radiopharmaceuticals Corporation Information
Table 59. Mallinckrodt Corporation Information
Table 60. Mallinckrodt Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 61. Mallinckrodt Main Product
Table 62. Mallinckrodt Recent Development
Table 63. Nordion Radiopharmaceuticals Corporation Information
Table 64. Nordion Corporation Information
Table 65. Nordion Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 66. Nordion Main Product
Table 67. Nordion Recent Development
Table 68. Triad Isotopes Radiopharmaceuticals Corporation Information
Table 69. Triad Isotopes Corporation Information
Table 70. Triad Isotopes Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 71. Triad Isotopes Main Product
Table 72. Triad Isotopes Recent Development
Table 73. Lantheus Radiopharmaceuticals Corporation Information
Table 74. Lantheus Corporation Information
Table 75. Lantheus Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 76. Lantheus Main Product
Table 77. Lantheus Recent Development
Table 78. IBA Group Radiopharmaceuticals Corporation Information
Table 79. IBA Group Corporation Information
Table 80. IBA Group Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 81. IBA Group Main Product
Table 82. IBA Group Recent Development
Table 83. GE Healthcare Radiopharmaceuticals Corporation Information
Table 84. GE Healthcare Corporation Information
Table 85. GE Healthcare Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 86. GE Healthcare Main Product
Table 87. GE Healthcare Recent Development
Table 88. China Isotope & Radiation Radiopharmaceuticals Corporation Information
Table 89. China Isotope & Radiation Corporation Information
Table 90. China Isotope & Radiation Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 91. China Isotope & Radiation Main Product
Table 92. China Isotope & Radiation Recent Development
Table 93. Jubilant Pharma Radiopharmaceuticals Corporation Information
Table 94. Jubilant Pharma Corporation Information
Table 95. Jubilant Pharma Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 96. Jubilant Pharma Main Product
Table 97. Jubilant Pharma Recent Development
Table 98. Eli Lilly Radiopharmaceuticals Corporation Information
Table 99. Eli Lilly Corporation Information
Table 100. Eli Lilly Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 101. Eli Lilly Main Product
Table 102. Eli Lilly Recent Development
Table 103. Advanced Accelerator Applications Radiopharmaceuticals Corporation Information
Table 104. Advanced Accelerator Applications Corporation Information
Table 105. Advanced Accelerator Applications Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 106. Advanced Accelerator Applications Main Product
Table 107. Advanced Accelerator Applications Recent Development
Table 108. SIEMENS Radiopharmaceuticals Corporation Information
Table 109. SIEMENS Corporation Information
Table 110. SIEMENS Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 111. SIEMENS Main Product
Table 112. SIEMENS Recent Development
Table 113. Dongcheng Radiopharmaceuticals Corporation Information
Table 114. Dongcheng Corporation Information
Table 115. Dongcheng Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 116. Dongcheng Main Product
Table 117. Dongcheng Recent Development
Table 118. Navidea Radiopharmaceuticals Corporation Information
Table 119. Navidea Corporation Information
Table 120. Navidea Radiopharmaceuticals Sales (K Dose), Revenue (Million US$), Price (USD/Dose) and Gross Margin (2015-2020)
Table 121. Navidea Main Product
Table 122. Navidea Recent Development
Table 123. Sales Base and Market Concentration Rate of Raw Material
Table 124. Key Suppliers of Raw Materials
Table 125. Radiopharmaceuticals Distributors List
Table 126. Radiopharmaceuticals Customers List
Table 127. Market Key Trends
Table 128. Key Opportunities and Drivers: Impact Analysis (2021-2026)
Table 129. Key Challenges
Table 130. Global Radiopharmaceuticals Sales (K Dose) Forecast by Type (2021-2026)
Table 131. Global Radiopharmaceuticals Sales Market Share Forecast by Type (2021-2026)
Table 132. Global Radiopharmaceuticals Revenue (Million US$) Forecast by Type (2021-2026)
Table 133. Global Radiopharmaceuticals Revenue (Million US$) Market Share Forecast by Type (2021-2026)
Table 134. Global Radiopharmaceuticals Sales (K Dose) Forecast by Application (2021-2026)
Table 135. Global Radiopharmaceuticals Revenue (Million US$) Forecast by Application (2021-2026)
Table 136. Global Radiopharmaceuticals Sales (K Dose) Forecast by Region (2021-2026)
Table 137. Global Radiopharmaceuticals Sales Market Share Forecast by Region (2021-2026)
Table 138. Global Radiopharmaceuticals Revenue Forecast by Region (2021-2026) (US$ Million)
Table 139. Global Radiopharmaceuticals Revenue Market Share Forecast by Region (2021-2026)
Table 140. Research Programs/Design for This Report
Table 141. Key Data Information from Secondary Sources
Table 142. Key Data Information from Primary Sources
List of Figures
Figure 1. Picture of Radiopharmaceuticals
Figure 2. Global Radiopharmaceuticals Sales Market Share by Type: 2020 VS 2026
Figure 3. Diagnostic Radioisotopes Product Picture
Figure 4. Therapeutic Radioisotopes Product Picture
Figure 5. Global Radiopharmaceuticals Consumption Market Share by Application: 2020 VS 2026
Figure 6. Oncology
Figure 7. Cardiology
Figure 8. Other
Figure 9. Global Radiopharmaceuticals Market Size 2015-2026 (US$ Million)
Figure 10. Global Radiopharmaceuticals Sales Capacity (K Dose) (2015-2026)
Figure 11. Global Radiopharmaceuticals Market Size Market Share by Region: 2020 Versus 2026
Figure 12. Radiopharmaceuticals Sales Share by Manufacturers in 2020
Figure 13. Global Radiopharmaceuticals Revenue Share by Manufacturers in 2019
Figure 14. The Global 5 and 10 Largest Players: Market Share by Radiopharmaceuticals Revenue in 2019
Figure 15. Radiopharmaceuticals Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 16. Global Radiopharmaceuticals Sales Market Share by Region (2015-2020)
Figure 17. Global Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 18. Global Radiopharmaceuticals Revenue Market Share by Region (2015-2020)
Figure 19. Global Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 20. North America Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 21. North America Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 22. U.S. Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 23. U.S. Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 24. Canada Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 25. Canada Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 26. Europe Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 27. Europe Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 28. Germany Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 29. Germany Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 30. France Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 31. France Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 32. U.K. Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 33. U.K. Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 34. Italy Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 35. Italy Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 36. Russia Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 37. Russia Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 38. Asia Pacific Radiopharmaceuticals Sales Market Share by Region in 2019
Figure 39. Asia Pacific Radiopharmaceuticals Revenue Market Share by Region in 2019
Figure 40. China Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 41. China Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 42. Japan Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 43. Japan Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 44. South Korea Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 45. South Korea Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 46. India Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 47. India Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 48. Australia Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 49. Australia Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 50. Taiwan Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 51. Taiwan Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 52. Indonesia Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 53. Indonesia Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 54. Thailand Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 55. Thailand Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 56. Malaysia Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 57. Malaysia Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 58. Philippines Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 59. Philippines Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 60. Vietnam Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 61. Vietnam Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 62. Latin America Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 63. Latin America Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 64. Mexico Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 65. Mexico Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 66. Brazil Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 67. Brazil Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 68. Argentina Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 69. Argentina Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 70. Middle East and Africa Radiopharmaceuticals Sales Market Share by Country in 2019
Figure 71. Middle East and Africa Radiopharmaceuticals Revenue Market Share by Country in 2019
Figure 72. Turkey Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 73. Turkey Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 74. Saudi Arabia Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 75. Saudi Arabia Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 76. U.A.E Radiopharmaceuticals Sales Growth Rate (2015-2020) (K Dose)
Figure 77. U.A.E Radiopharmaceuticals Revenue Growth Rate (2015-2020) (US$ Million)
Figure 78. Sales Market Share of Radiopharmaceuticals by Type (2015-2020)
Figure 79. Sales Market Share of Radiopharmaceuticals by Type in 2019
Figure 80. Revenue Share of Radiopharmaceuticals by Type (2015-2020)
Figure 81. Revenue Market Share of Radiopharmaceuticals by Type in 2019
Figure 82. Global Radiopharmaceuticals Sales Growth by Type (2015-2020) (K Dose)
Figure 83. Global Radiopharmaceuticals Sales Market Share by Application (2015-2020)
Figure 84. Global Radiopharmaceuticals Sales Market Share by Application in 2019
Figure 85. Global Revenue Share of Radiopharmaceuticals by Application (2015-2020)
Figure 86. Global Revenue Share of Radiopharmaceuticals by Application in 2020
Figure 87. Bracco Imaging Total Revenue (US$ Million): 2019 Compared with 2018
Figure 88. Bayer Total Revenue (US$ Million): 2019 Compared with 2018
Figure 89. Mallinckrodt Total Revenue (US$ Million): 2019 Compared with 2018
Figure 90. Nordion Total Revenue (US$ Million): 2019 Compared with 2018
Figure 91. Triad Isotopes Total Revenue (US$ Million): 2019 Compared with 2018
Figure 92. Lantheus Total Revenue (US$ Million): 2019 Compared with 2018
Figure 93. IBA Group Total Revenue (US$ Million): 2019 Compared with 2018
Figure 94. GE Healthcare Total Revenue (US$ Million): 2019 Compared with 2018
Figure 95. China Isotope & Radiation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 96. Jubilant Pharma Total Revenue (US$ Million): 2019 Compared with 2018
Figure 97. Eli Lilly Total Revenue (US$ Million): 2019 Compared with 2018
Figure 98. Advanced Accelerator Applications Total Revenue (US$ Million): 2019 Compared with 2018
Figure 99. SIEMENS Total Revenue (US$ Million): 2019 Compared with 2018
Figure 100. Dongcheng Total Revenue (US$ Million): 2019 Compared with 2018
Figure 101. Navidea Total Revenue (US$ Million): 2019 Compared with 2018
Figure 102. Price Trend of Key Raw Materials
Figure 103. Manufacturing Cost Structure of Radiopharmaceuticals
Figure 104. Manufacturing Process Analysis of Radiopharmaceuticals
Figure 105. Radiopharmaceuticals Industrial Chain Analysis
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Porter's Five Forces Analysis
Figure 109. North America Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026)
Figure 110. North America Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 111. Europe Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026)
Figure 112. Europe Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 113. Latin America Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026)
Figure 114. Latin America Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 115. Middle East and Africa Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026)
Figure 116. Middle East and Africa Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 117. Asia Pacific Radiopharmaceuticals Sales (K Dose) and Growth Rate Forecast (2021-2026)
Figure 118. Asia Pacific Radiopharmaceuticals Revenue (Million US$) and Growth Rate Forecast (2021-2026)
Figure 119. Bottom-up and Top-down Approaches for This Report
Figure 120. Data Triangulation
Figure 121. Key Executives Interviewed

• Clinical Results in Diabetics To Be Boosted By Smart Artificial Beta Cells

For a long time, the cure for diabetes type 1 and type 2 has relied on agonizing insulin shots for patients or insulin infusion via mechanical pumps. Regarding this, experts have been creating artificial pancreatic beta cells with the he…

• High-speed Data Transmission And High Volume Needs Propel Fiber Optic Connectors Market

Fiber optic connectors are a substantial fragment of the global telecommunication industry. Optical fibers are joined using fiber optic connectors, which allow the light conduction between two consecutive optical fibers. An additional im…

• Extensive Use of Digital Technologies for Diagnostic Applications To Boost Global Optical Imaging Market

The global optical imaging system market is predicted to reach US$ 3 billion by 2024. It is expected to grow at a stable rate and will post a CAGR of more than 8% in the coming years. The growing market infiltration of digital …

• Foremost Trends In Global Pet Care Market

The global pet care market is foretold to improve in the forthcoming years as matched to the preceding years and will showcase better sales in various market segments. It is estimated that the global pet care market will grow at a CAGR o…

• China To Review Its Food Security Laws

China has arisen as the globe’s firmest developing economy. In addition, China brags about the biggest population pool in the world. In recent times, the one child policy in the republic was terminated. This is anticipated to upsur…

Global Radiopharmaceutical Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 125

According to our LPI (LP Information) latest study, the global Radiopharmaceutical market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceutical is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceutical market. Radiopharmaceutical are expected to show stable growth in the future market. However, produ......

Global Radiopharmaceuticals Market Growth 2024-2030

Published: 04-Jan-2024        Price: US 3660 Onwards        Pages: 138

According to our LPI (LP Information) latest study, the global Radiopharmaceuticals market size was valued at US$ 6613.9 million in 2023. With growing demand in downstream market, the Radiopharmaceuticals is forecast to a readjusted size of US$ 11560 million by 2030 with a CAGR of 8.3% during review period. The research report highlights the growth potential of the global Radiopharmaceuticals market. Radiopharmaceuticals are expected to show stable growth in the future market. However, p......

Global Radiopharmaceutical Market 2024 by Manufacturers, Regions, Type and Application, Forecast to 2030

Published: 01-Jan-2024        Price: US 3480 Onwards        Pages: 137

According to our (Global Info Research) latest study, the global Radiopharmaceutical market size was valued at USD 6956.7 million in 2023 and is forecast to a readjusted size of USD 11660 million by 2030 with a CAGR of 7.7% during review period. Radiopharmaceuticals are radioactive compounds administered to the patient, and monitored via specific imaging devices, for diagnosis and therapeutic purposes. It is composed of a radioisotope bond to an organic molecule. The organic molecule con......

Global Radiation Dose Management Market Research Report 2023

Published: 28-Dec-2023        Price: US 2900 Onwards        Pages: 88

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Radiation Dose Management market with multiple angles, which provides sufficient supports to readers' strategy and decision making. By Company - Landauer - Sectra AB - Afga-Gevaert - INFINITT Healthcare - Bayer Healthcare - PACSHealth - Koninklijke Philips - GE Healthcar......

Global Radiation Dose Management Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 21-Dec-2023        Price: US 3380 Onwards        Pages: 111

Market Overview of Global Radiation Dose Management market: According to our latest research, the global Radiation Dose Management market looks promising in the next 5 years. As of 2022, the global Radiation Dose Management market was estimated at USD 484.67 million, and it's anticipated to reach USD 1069.95 million in 2028, with a CAGR of 14.11% during the forecast years. The radiation dose management channel includes information of radiation dose recording software, real-ti......

Global Radiation Dose Management Market Research Report 2024 (Status and Outlook)

Published: 15-Dec-2023        Price: US 3200 Onwards        Pages: 124

Report Overview: The Global Radiation Dose Management Market Size was estimated at USD 862.70 million in 2022 and is projected to reach USD 3695.44 million by 2029, exhibiting a CAGR of 23.10% during the forecast period. This report provides a deep insight into the global Radiation Dose Management market covering all its essential aspects. This ranges from a macro overview of the market to micro details of the market size, competitive landscape, development trend, niche marke......

Global Radiopharmaceutical Professional Survey Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 3280 Onwards        Pages: 133

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......

Global Radiopharmaceutical Market Research Report 2023, Forecast to 2028

Published: 21-Nov-2023        Price: US 2680 Onwards        Pages: 166

Radiopharmaceuticals are unique medicinal formulations containing radioisotopes which are used in major clinical areas for diagnosis and/or therapy. Our market research experts provide qualitative and quantitative analysis of the market based on involving economic and non-economic factors in the same report with market value (million USD) data for each segment and sub-segment. This way, clients can achieve all their goals while taking advantage of emerging opportunities. Technological adv......

Global Radiopharmaceutical Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028

Published: 14-Nov-2023        Price: US 3380 Onwards        Pages: 116

Market Overview of Global Radiopharmaceutical market: According to our latest research, the global Radiopharmaceutical market looks promising in the next 5 years. As of 2022, the global Radiopharmaceutical market was estimated at USD 7319.21 million, and it's anticipated to reach USD 13640.5 million in 2028, with a CAGR of 10.93% during the forecast years. This report covers a research time span from 2018 to 2028, and presents a deep and comprehensive analysis of the global R......

We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s. Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors. Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business. Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision. Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us. Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done. Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements. Subscription Offers & Packages (Get in touch with us for more details - [email protected] / +1 888 391 5441 )

• Ad Hoc
• Pay - as - you - go / Bucket Subscriptions
• Fixed Cost for #of reports
• Customize / Personalize as per your needs